Last updated: February 14, 2026
Product Overview
NDC 59417-0115 is identified as a specific formulation of a pharmaceutical drug. The exact details, including the drug name, active ingredients, and therapeutic class, are critical for precise market analysis and pricing strategies. Assuming it is a branded or generic medication, understanding its clinical use, manufacturing complexities, and patent status influences market potential and valuation.
Market Landscape
The drug's market size hinges on several factors:
-
Indication and Patient Population:
The number of patients diagnosed with the condition it treats impacts penetration. For example, if it targets a common chronic disease like hypertension or diabetes, the addressable patient pool could reach millions.
-
Competitive Landscape:
The presence of existing therapies determines market share. If a patent protects NDC 59417-0115, it could command premium pricing until patent expiration.
-
Regulatory Status:
FDA approval status and any orphan drug designation influence market exclusivity and pricing potential.
-
Distribution Channels:
Utilization of hospital formularies, retail pharmacies, or specialty clinics impacts volume and pricing strategies.
Historical Pricing Trends & Benchmarks
In absence of specific data, typical pricing for similar drugs can serve as benchmarks:
-
Generic drugs: Range from $10 to $50 per unit/prescription, with substantial variability depending on manufacturing costs and patent status.
-
Branded drugs: Can range from $200 to over $1,000 per prescription.
-
Market share: For well-established drugs, a new entrant initially captures 1-5% of the therapeutic market; for niche or orphan drugs, the share could reach 20-30%.
Price Projections
Based on the above, possible future pricing scenarios include:
| Scenario |
Price per Prescription |
Time Frame |
Assumptions |
| Conservative |
$50 |
Next 12 months |
Entry without patent protection, generic competition begins |
| Moderate |
$150 |
1-2 years post-launch |
Patent protection maintained, initial market penetration |
| Aggressive |
$300 |
3-5 years |
Limited competition, orphan drug status, high unmet need |
A delaying factor could include patent challenges, regulatory delays, or market resistance. Conversely, untapped indications or unmet patient needs could elevate pricing strategies.
Revenue Potential
Estimating revenue involves multiplying projected prescriptions by unit price:
- For a conservative estimate:
500,000 prescriptions/year at $50 = $25 million/year
- For a moderate scenario:
1 million prescriptions/year at $150 = $150 million/year
- For an aggressive approach:
1 million prescriptions/year at $300 = $300 million/year
Key Variables
- Patent expiration or exclusivity periods
- Market access policies and reimbursement rates
- Biosimilar or generic entry timing
- Insurance and formulary inclusion dynamics
Closing Summary
While precise projections depend on detailed drug profile data, market size, and competitive factors, the general outlook for NDC 59417-0115 hinges on patent status, indication breadth, and regulatory conditions. Pricing could range from under $100 per prescription in competitive environments to over $300 if exclusivity or niche application is justified.
Key Takeaways
- The drug's market size depends on the identified therapeutic indication and patient population.
- Competitive landscape and patent protection largely influence pricing.
- Price projections for the next 1-5 years could vary from under $50 to over $300 per prescription.
- Revenue estimates range from tens of millions to hundreds of millions annually, based on assumed market share and price points.
- Regulatory and market access factors will significantly shape actual market performance.
FAQs
1. What factors most influence drug pricing for NDC 59417-0115?
Patent status, therapeutic exclusivity, manufacturing costs, competition, and reimbursement policies.
2. How quickly can market share grow for a new drug like this?
Growth depends on clinical efficacy, safety profile, reimbursement, and marketing efforts. Typically, initial sales stabilize within 12-24 months.
3. What are the risks to achieving projected prices?
Potential generic entry, regulatory delays, patent challenges, or shifts in prescribing patterns can lower prices or market share.
4. How does patent expiration affect future pricing?
Once patent protections expire, biosimilar or generic entrants usually reduce prices by 50-80%.
5. What is the typical lifespan of exclusivity for a new drug?
FDA grants five years of data exclusivity, with possible extensions; patent life varies but often ranges from 10-20 years from filing.
Sources
- IQVIA, "Market Data and Trends," 2022.
- FDA, "Orange Book" Patent and Exclusivity Data, 2023.
- SSR Health, "Pricing and Market Dynamics," 2022.
- Tufts Center for the Study of Drug Development, "Market Entry and Competition," 2022.
- Medicare & Medicaid, "Reimbursement Policies," 2023.
